COVID-19 May Lead To Another Epidemic of Brain Damage

One in eight COVID-19 survivors are diagnosed with a neurological or psychiatric illness for the first time in their lives, six months after their bout of the disease.

One in eight COVID-19 survivors are diagnosed with a neurological or psychiatric illness for the first time in their lives, six months after their bout of the disease as per a study led by researchers at the University of Oxford and the Oxford University Hospitals NHS Foundation Trust in the United Kingdom, published on the pre-print medRxiv* server.

The incidence of International Classification of Diseases 10 (ICD-10) diagnoses in the six months after being diagnosed with COVID-19, was estimated by the team. Conditions included were intracranial hemorrhage, ischemic stroke, Guillain-Barre’ syndrome, Parkinsonism, nerve root disorders, muscle disease, dementia, encephalitis, anxiety, psychotic disorders, substance misuse, and insomnia.

COVID-19 Causes Brain Storm
The S1 spike protein of the COVID-19 virus causes cognitive effects, such as brain fog, and fatigue in infected patients by crossing the blood-brain barrier.

‘One in eight COVID-19 survivors are diagnosed with a neurological or psychiatric illness for the first time in their lives, six months after their bout of the disease. This growing evidence of coronavirus impact on short- and long-term cognitive and mental health issues, seeks the need for further research and follow-up among these patients.’

Retrospective cohort studies and time-to-event analysis were utilized by the study team to estimate the incidence of ICD-10 diagnoses in the six months after COVID-19 detection. The electronic health records (TriNetX) of 236,379 US coronavirus survivors were analyzed.

Neurological manifestations of COVID-19

It was found that within six months, 33.6% of the coronavirus survivors received a neurological or psychiatric diagnosis; 13% received such a diagnosis for the first time. Encephalopathy was diagnosed especially in those who've been hospitalized.

Dementia Worsens COVID-19
Cognitive disorders like Alzheimer’s disease and dementia are predominantly found to increase the risk for acquiring severe COVID-19, said new study.

"For diagnoses like a stroke or an intracranial bleed, the risk does tend to decrease quite dramatically within six months. But for a few neurological and psychiatric diagnoses, we don't have the answer about when it's going to stop", says Dr. Max Taquet, Department of psychiatry at the University of Oxford.

Earlier studies have reported a wide range of cognitive and neurological consequences, like head and muscle aches, confusion and dizziness, seizures and strokes, and brain swelling and delirium.

'Brain Fog' Behind Body Inflammation?
Scientists have uncovered a possible solution for the mental sluggishness or mental fatigue that often accompanies illness, reports a new study.

The virus may impact the lungs and heart, making it difficult for the brain to get enough oxygen, thereby causing neurological complications. Other causal factors may include the immune system's response that can result in the inflammation that damages the brain and nerves, or the viral invasion into the brain itself.

There is a constant concern of permanent brain damage in these individuals leading to yet another epidemic of brain damage.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

"My worry is that we have millions of people with COVID-19 now. And if in a year's time we have 10 million recovered people, and those people have cognitive deficits. Then that's going to affect their ability to work and their ability to go about activities of daily living," says Adrian Owen, a neuroscientist at Western University in Canada.

Thus the growing evidence of coronavirus impact on short- and long-term cognitive and mental health issues, seeks the need for further research and follow-up among convalescents.

Source-Medindia